Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome


KANBAY A., Ceylan E., Koseoglu H. I. , ÇALIŞKAN M., Takir M., Tulu S., ...More

CLINICAL RESPIRATORY JOURNAL, vol.12, no.1, pp.84-90, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1111/crj.12487
  • Title of Journal : CLINICAL RESPIRATORY JOURNAL
  • Page Numbers: pp.84-90

Abstract

Background and Aims: Obstructive sleep apnea syndrome (OSA) is an independent risk factor for endothelial dysfunction and cardiometabolic diseases. Plasma endocan levels are elevated in a large number of diseases, and is a novel surrogate endothelial cell dysfunction marker. We aimed to assess the role of serum endocan level as a potential mechanism of endothelial dysfunction in OSA patients.